Hello fellow MPNers. After listening to the interview with Blood Cancer UK on BBC R4, concerning the effectiveness of vaccines in providing protection to blood cancer sufferers, I ended up with more questions than answers. So I e-mailed BCUK asking for information specifically for MPNs rather than the broad spectrum of blood cancers. Within a matter of hours I received a very comprehensive response from them, which I think is well worth sharing. To make sense of it, I have copied below my original request and their response in full (so this is going to be a long post!). There is still much that I don't understand (I suspect I am in good company there!), but I found this very helpful.
BCUK asked me to include this message to you all:
If you could kindly include links to our support services (bloodcancer.org.uk/support-... we would be very grateful. This way we can support those who might have additional questions or concerns about any of the issues raised.
I hope you find it useful.
John
++++++++++++++++++++++++++++++++++++++++++++++++++++++++
I have read a lot recently about the effectiveness of Covid vaccines for people with blood cancer, and I also heard your Radio 4 interview.
I am well aware that the term 'blood cancer' covers a wide spectrum of diseases, from chronic to acute and debilitating to inconvenient. I am a 71 year old male with ET jak2+, taking hydroxycarbamide. I have always considered ET to be at the more benign end of the blood cancer scale, and as such I am somewhat confused regarding the extent to which this current concern (lack of protection from vaccinations) is relevant to MPN sufferers in general and ET sufferers in particular.
I would greatly appreciate clarification please.
John
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++
Good morning John,
Thank you for reaching out to Blood Cancer UK, you’re right to want to know more considering the concerns about the effectiveness of the vaccine for people with Essential Thrombocythemia, such as yourself.
We still don't know the effectiveness of the vaccine for people with blood cancer, and so we would strongly encourage people who are clinically extremely vulnerable to continue to take precautions to avoid the virus.
As more people have the vaccine, we will learn more about how effective it is in people with blood cancer, and will keep updating our information. As you'll know, the best people to offer you advice around your individual circumstances and medical history, will be members of your healthcare team, so don't be afraid to get in touch with them to talk things through and get their advice if you have any concerns. You might find it helpful to also take a look at our webpage which aims to help people think about their own individual risk to Covid-19 Understanding your Level of Risk.
You are correct that the term “Blood Cancer” does cover a wide range of cancers, each of which can have very different symptoms, treatments, and outcomes. As part of our Vaccine Research Collaborative we are funding a wide range of studies, some of which include people with ET. Early data suggests that in people with slow-growing, chronic blood cancers such as CLL, CML, follicular lymphoma and MPNs, there are mixed results about whether being in remission, being on treatment, or having different types of treatment, makes a difference to covid vaccine efficacy.
We are working with our research network to develop practical steps for monitoring immune response after vaccination for blood cancer patients. You may want to take a look at this page of our website as it talks about the different research studies, including research into people with MPN’s such as ET: bloodcancer.org.uk/support-...
There are many trials and studies looking at the covid vaccine in cancer patients, in immunocompromised people, and some in people with blood cancer specifically – some of which you can sign up to. You can find further details about these studies on our website here: bloodcancer.org.uk/support-.... We are continuing to try to find out more about the various research projects underway, so we can tell you how people with blood cancer will be monitored. We will update our information on this as soon as we know more.
I would also like to take some time to mention antibody tests. As you may know, there are concerns in the research community about antibody tests not providing the full picture about immunity, as we still don't know what part of the immune system is necessary for immunity to coronavirus. Questions remain about whether it is 100% antibody or 100% T-cell, or a mixture of both. At this time, there isn't certainty about what antibody test results mean for a person's immune status.
You may find our blog on antibody testing on our webpage helpful in understand this further: Covid vaccine: should people with blood cancer get an antibody test? | Blood Cancer UK.
In this clip from our 'Ask the Experts Q&A' on the Covid-19 vaccine, the panel discusses the important question of how we will know how the Covid-19 vaccines work in people with blood cancer. Dr Graham Collins provides information about what to look for and what to be mindful of when thinking about antibody tests and their results - youtube.com/watch?v=5coAg7T...
An antibody test is currently not given to patients by default, and availability varies from place to place, as is discussed in this clip: youtube.com/watch?v=S4BkFPp... . Additionally, there are currently two different types of antibody tests, and the one most routinely available does not look at the spike protein - which is the antibody that you would expect to appear after you have a vaccine.
It’s really important to highlight that everyone is individual, and there are so many factors which could determine a person’s response to a vaccine. We would really encourage people to speak to their healthcare teams if they have any questions or concerns around their immune response to the vaccine.
It’s also really important to highlight that now there is emerging evidence that vaccines reduce transmission, the success of the vaccine roll out is good news, as it will be a really important factor in protecting people who have little or no response to the Covid vaccine themselves.
This may be quite a lot of information to process so if there’s anything you want to talk through, anything we can do to support you, we’re only an email or a phone call away on 0808 2080 888 or support@bloodcancer.org.uk.
Enjoy the rest of your day,
Sophie
Sophie Stephenson, MSc
Support Services Officer
Clinical Trials Support Services Coordinator